During the past decade, Collaborative Neuroscience Research, LLC conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 4 clinical trials were completed, i.e. on average, 9.3% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 3 clinical trials were completed. i.e. 7.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Collaborative Neuroscience Research, LLC" #1 sponsor was "Sunovion" with 7 trials, followed by "Karuna Therapeutics" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "BioNTech SE" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Collaborative Neuroscience Research, LLC" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Collaborative Neuroscience Research, LLC" are "Schizophrenia" (16 trials), "COVID-19" (3 trials), "Healthy" (3 trials), "Alzheimer Disease" (2 trials) and "Depressive Episodes, Bipolar I Depression" (2 trials). Many other conditions were trialed in "Collaborative Neuroscience Research, LLC" in a lesser frequency.

Most popular intervention types in "Collaborative Neuroscience Research, LLC" are "Drug" (46 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Xanomeline and Trospium Chloride Capsules" (5 trials), "BI 425809" (2 trials), "BNT162b2" (2 trials) and "Dihydroergotamine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Collaborative Neuroscience Research, LLC" are 47 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Collaborative Neuroscience Research, LLC". undefined are not yet recruiting, 17 are recruiting, 3 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 20 completed trials in Collaborative Neuroscience Research, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Collaborative Neuroscience Research, LLC, 15 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".